Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$177M |
Are Vanda Pharmaceuticals Insiders Buying or Selling?
Vanda Pharmaceuticals (VNDA) has had no reported insider transactions in the past 90 days. The most recent was Polymeropoulos Mihael Hristos, who sold 156,235 shares at $8.17 on March 2, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the VNDA AI Score. For government officials trading this stock, see VNDA congressional trading.
Who’s Trading Vanda Pharmaceuticals Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| Polymeropoulos Mihael Hristos | Sold $1.3M | 12 | Mar 2, 2026 |
| Moran Kevin Patrick | Sold $350,000 | 2 | Mar 2, 2026 |
| Timothy Williams | Sold $350,000 | 1 | Mar 2, 2026 |
| Gunther Birznieks | Sold $350,000 | 1 | Mar 2, 2026 |
| Joakim Wijkstrom | Sold $250,000 | 1 | Mar 2, 2026 |
| Tage Honore | Sold $240,000 | 1 | Feb 23, 2026 |
Recent Vanda Pharmaceuticals Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Polymeropoulos Mihael Hristos | Mar 2, 2026 | Sell | 156,235 | $8.17 | $1.3M |
| Moran Kevin Patrick | Mar 2, 2026 | Sell | 42,442 | $8.27 | $350,000 |
| Joakim Wijkstrom | Mar 2, 2026 | Sell | 30,800 | $8.27 | $250,000 |
| Timothy Williams | Mar 2, 2026 | Sell | 42,434 | $8.27 | $350,000 |
| Gunther Birznieks | Mar 2, 2026 | Sell | 42,431 | $8.27 | $350,000 |
| Tage Honore | Feb 23, 2026 | Sell | 30,000 | $8.03 | $240,000 |
| Polymeropoulos Mihael Hristos | Aug 7, 2025 | Buy | 10,000 | $4.15 | $42,000 |
| Mitchell Stephen Ray | Jun 13, 2025 | Sell | 7,000 | $4.59 | $32,000 |
| Polymeropoulos Mihael Hristos | May 21, 2025 | Buy | 9,519 | $4.4 | $42,000 |
| Polymeropoulos Mihael Hristos | May 21, 2025 | Buy | 481 | $4.39 | $2,100 |
| Polymeropoulos Mihael Hristos | May 16, 2025 | Buy | 20,000 | $4.22 | $84,000 |
| Polymeropoulos Mihael Hristos | Mar 6, 2025 | Buy | 5,000 | $5.01 | $25,000 |
| Polymeropoulos Mihael Hristos | Mar 5, 2025 | Buy | 5,000 | $5.03 | $25,000 |
| Polymeropoulos Mihael Hristos | Mar 3, 2025 | Buy | 10,000 | $4.71 | $47,000 |
| Polymeropoulos Mihael Hristos | Feb 28, 2025 | Buy | 10,000 | $4.76 | $48,000 |
| Polymeropoulos Mihael Hristos | Feb 27, 2025 | Buy | 10,000 | $4.76 | $48,000 |
| Polymeropoulos Mihael Hristos | Feb 26, 2025 | Buy | 5,000 | $4.78 | $24,000 |
| Polymeropoulos Mihael Hristos | Feb 25, 2025 | Buy | 10,000 | $4.46 | $45,000 |
| Moran Kevin Patrick | Feb 21, 2025 | Buy | 2,000 | $4.39 | $8,800 |
| Mitchell Stephen Ray | Nov 14, 2024 | Sell | 5,000 | $5.17 | $26,000 |
Frequently Asked Questions: Vanda Pharmaceuticals Insider Trading
Vanda Pharmaceuticals insiders have not reported any transactions in the past 90 days.
The most recent sale was by Polymeropoulos Mihael Hristos who sold 156,235 shares on March 2, 2026. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Polymeropoulos Mihael Hristos has bought the most VNDA stock in the last 2 years, with a total value of $430,000.
Polymeropoulos Mihael Hristos has sold the most VNDA stock in the last 2 years, with a total value of $1.3M.
The total value of insider transactions for Vanda Pharmaceuticals in the last 2 years is negative, amounting to -$2.4M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
